Is Berkshire The Best Stock to Buy in a Bad Market?
Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…
Sell
47
NICE Quote, Financials, Valuation and Earnings
Last price:
$157.89
Seasonality move
:
7.35%
Day range:
$155.82 - $160.26
52-week range:
$137.19 - $229.33
Dividend yield:
0%
P/E ratio:
23.37x
P/S ratio:
3.78x
P/B ratio:
2.78x
Volume:
166K
Avg. volume:
391.8K
1-year change:
-28.66%
Market cap:
$10B
Revenue:
$2.7B
EPS (TTM):
$6.76
Analysts' Opinion
-
Consensus RatingNICE has received a consensus rating of Buy. The company's average rating is a Buy based on 10 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $209.07, NICE has an estimated upside of 32.31% from its current price of $158.01.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $153.00 representing 3.17% downside risk from its current price of $158.01.
Fair Value
-
According to the consensus of 14 analysts, NICE has 32.31% upside to fair value with a price target of $209.07 per share.
NICE vs. S&P 500
-
Over the past 5 trading days, NICE has underperformed the S&P 500 by -0.28% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
NICE does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
NICE has grown year-over-year revenues for 38 quarters straight. In the most recent quarter NICE reported revenues of $721.6M.
Earnings Growth
-
NICE has grown year-over-year earnings for 12 quarters straight. In the most recent quarter NICE reported earnings per share of $1.54.
Enterprise value:
8.8B
EV / Invested capital:
--
Price / LTM sales:
3.78x
EV / EBIT:
14.62x
EV / Revenue:
3.23x
PEG ratio (5yr expected):
0.71x
EV / Free cash flow:
12.07x
Price / Operating cash flow:
14.12x
Enterprise value / EBITDA:
10.92x
Gross Profit (TTM):
$1.8B
Return On Assets:
8.61%
Net Income Margin (TTM):
16.18%
Return On Equity:
12.67%
Return On Invested Capital:
11.09%
Operating Margin:
21.39%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $2.2B | $2.4B | $2.7B | $623.2M | $721.6M | |
| Gross Profit | $1.5B | $1.6B | $1.8B | $422.3M | $489.2M | |
| Operating Income | $335.2M | $435.2M | $546M | $122.7M | $154.3M | |
| EBITDA | $525.6M | $628.8M | $810M | $190.1M | $262.1M | |
| Diluted EPS | $4.00 | $5.09 | $6.76 | $1.24 | $1.54 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.9B | $2.3B | $2.4B | $2.3B | $2.5B | |
| Total Assets | $4.2B | $4.7B | $4.9B | $5.1B | $5.3B | |
| Current Liabilities | $1B | $1.3B | $1.1B | $1.1B | $1.5B | |
| Total Liabilities | $1.6B | $1.9B | $1.8B | $1.8B | $1.7B | |
| Total Equity | $2.6B | $2.8B | $3.1B | $3.4B | $3.6B | |
| Total Debt | $681.2M | $825.2M | $664.7M | $666.3M | $458.8M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $479.7M | $561.4M | $832.6M | $180.5M | $249.5M | |
| Cash From Investing | -$152.4M | -$293.6M | -$397.4M | -$317.3M | -$330.4M | |
| Cash From Financing | -$164.5M | -$290.3M | -$456.6M | -$69.6M | -$94.8M | |
| Free Cash Flow | $397.8M | $477.3M | $732.9M | $160.5M | $225.1M | |
NICE
Sector
Market Cap
$10B
$78.1M
Price % of 52-Week High
68.9%
58.31%
Dividend Yield
0%
0%
Shareholder Yield
3.77%
0.8%
1-Year Price Total Return
-28.66%
-16.75%
Beta (5-Year)
1.029
0.847
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$156.21
200-day SMA
Sell
Level
$168.09
Bollinger Bands (100)
Sell
Level
148.81 - 175.19
Chaikin Money Flow
Buy
Level
46.8M
20-day SMA
Buy
Level
$152.22
Relative Strength Index (RSI14)
Buy
Level
56.98
ADX Line
Buy
Level
8.96
Williams %R
Sell
Level
-12.8256
50-day SMA
Buy
Level
$150.89
MACD (12, 26)
Buy
Level
1.23
25-day Aroon Oscillator
Buy
Level
80
On Balance Volume
Neutral
Level
36.3M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (5.649)
Buy
CA Score
(Annual)
Level (1.0248)
Buy
Beneish M-Score
(Annual)
Level (-2.4786)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (-2.5339)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Nice is an enterprise software company that serves the customer engagement and financial crime and compliance markets. The company provides data analytics-based solutions through both a cloud platform and on-premises infrastructure. Within customer engagement, Nice’s CXone platform delivers solutions focused on contact center software and workforce engagement management, or WEM. Contact center offerings include solutions for digital self-service, customer journey and experience optimization, and compliance. WEM products optimize call center efficiency, leveraging data and AI analytics for call volume forecasting and agent scheduling. Within financial crime and compliance, Nice offers risk and investigation management, fraud prevention, anti-money laundering, and compliance solutions.
Stock Forecast FAQ
In the current month, NICE has received 10 Buy ratings 4 Hold ratings, and 0 Sell ratings. The NICE average analyst price target in the past 3 months is $209.07.
-
Where Will NICE Stock Be In 1 Year?
According to analysts, the consensus estimate is that NICE share price will rise to $209.07 per share over the next 12 months.
-
What Do Analysts Say About NICE?
Analysts are divided on their view about NICE share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that NICE is a Sell and believe this share price will drop from its current level to $153.00.
-
What Is NICE's Price Target?
The price target for NICE over the next 1-year time period is forecast to be $209.07 according to 14 Wall Street analysts, 10 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is NICE A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for NICE is a Buy. 10 of 14 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of NICE?
You can purchase shares of NICE via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase NICE shares.
-
What Is The NICE Share Price Today?
NICE was last trading at $157.89 per share. This represents the most recent stock quote for NICE. Yesterday, NICE closed at $158.01 per share.
-
How To Buy NICE Stock Online?
In order to purchase NICE stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
The big picture trends in e‑commerce sales are clearly in…
Is RTX The Best Growth Stock?
Among the worldwide aerospace and defense markets, the US controls…
Stock Ideas
Buy
71
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
63
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 6
Regencell Bioscience Holdings [RGC] is up 152.58% over the past day.
Buy
63
SKX alert for May 6
Skechers USA [SKX] is up 0.02% over the past day.
Sell
20
PTCT alert for May 6
PTC Therapeutics [PTCT] is down 6.15% over the past day.
